ComposableStack.AI CDP
Back to agent
Vendorvendor.freshpaint

Freshpaint

Healthcare Privacy Platform that automatically detects and blocks PHI before forwarding behavioral event data to downstream analytics and marketing tools. HHS guidance (March 2024) explicitly named CDPs like Freshpaint as viable alternatives to non-BAA tracking technologies. Uses server-side cryptographic hashing (irreversible) and ID masking to de-identify data at the tracking layer — enabling HIPAA-compliant performance marketing by replacing non-BAA tracking pixels (Google, Facebook) with a BAA-supported CDP layer. Not a general-purpose CDP — Freshpaint is a healthcare-vertical specialist focused on the tracking-layer PHI interception problem.

confidence 75%v1reviewed May 11, 2026freshpaint, healthcare, hipaa, phi, privacy, cdp, healthcare-privacy-platform, hhs-cited, baa, phi-detection, phi-suppression, behavioral-tracking

Freshpaint is a Healthcare Privacy Platform that sits between the website/app event layer and downstream analytics and marketing tools. Its differentiated function is automatic PHI detection and interception: behavioral event streams are inspected in real time and any fields matching HIPAA Safe Harbor identifiers (email, name, IP address, date of birth, etc.) are suppressed before data is forwarded to downstream destinations (Google Analytics, Meta Pixel, HubSpot, Salesforce).

This architecture enables HIPAA-compliant performance marketing analytics without requiring a manual de-identification pipeline: the PHI suppression happens at the tracking layer, not as a batch CDW transformation. Downstream destinations receive behavioral event data with PHI fields removed — making the forwarded data not PHI and therefore flowable to ad platforms that cannot sign a BAA (Meta, Google). Cryptographic hashing is irreversible (as required by the Safe Harbor standard); original PHI is not reconstructible from the forwarded data.

HHS relevance. In March 2024, HHS updated its bulletin on tracking technologies and explicitly cited CDPs like Freshpaint as architecturally appropriate for healthcare providers who need third-party analytics and marketing tools without routing PHI to non-BAA vendors. This HHS guidance is the strongest available regulatory endorsement for a category of tool.

Why this is distinct from BAA-holding CDPs. Most general-purpose CDPs (Hightouch, Tealium, Adobe, Salesforce) can sign BAAs, making them HIPAA-compliant for PHI-containing workflows. Freshpaint's differentiation is pre-emptive PHI suppression at the edge: it addresses the tracking-layer problem (the website fires a pixel before any CDW transformation can occur) that BAA-holding CDPs do not solve. The two approaches are complementary — Freshpaint handles tracking-layer compliance; a BAA-holding CDP handles downstream activation.

Confidence note: AdExchanger editorial URL retained in web-refresh queue (403-blocked). When fetched, this independent trade media source would raise confidence from 0.75 to ≥ 0.80. Merged at current confidence.

Sources

Related

This node →

  • alternative-topattern.fail-fast-within-compliance— Freshpaint's PHI-suppression-at-tracking-layer approach is a vendor implementation of the fail-fast-within-compliance pattern: PHI is intercepted before it reaches non-BAA destinations rather than filtered post-facto. The vendor embodies the pattern.
  • addressesconstraint.hipaa-phi-cdp-healthcare— Freshpaint's tracking-layer PHI suppression directly addresses the HIPAA Marketing Rule's prohibition on routing PHI to non-BAA ad platforms — allowing healthcare organizations to use performance marketing analytics that would otherwise violate HIPAA.
  • governed-byconstraint.hipaa-security-rule-2026— Freshpaint is a HIPAA-compliant healthcare analytics platform. The 2026 HIPAA Security Rule modernization (MFA, mandatory encryption, asset inventories, 24-hour breach notification for business associates) applies to all access paths to ePHI in Freshpaint's pipeline. Translation note: TC-76 proposal authored edge as constraint→constrains→vendor; Synthesizer translated to schema-valid reverse-direction governed-by edge.

← Referenced by

  • involves-vendorarchetype.healthcare-provider-hipaa-performance-marketing— OC-047. Freshpaint is the incumbent tracking-layer PHI suppression vendor referenced in this archetype. It is explicitly named in HHS March 2024 tracking-technology guidance as an architecturally appropriate solution. The archetype's recommended direction (server-side event collection with PHI suppression before non-BAA destinations) is the Freshpaint product architecture.